Under the programme, by 2030, the sector strives to meet 20% of the domestic demand for raw materials for drug production; and 50% of the demand for raw materials for the production of supplementary foods and cosmeceuticals. The export growth rate of certain natural chemical-pharmaceutical products including active ingredients, standardised extracts, essential oils rich in active substances is targeted to reach over 10% per year.

By 2045, Vietnam's chemical-pharmaceutical industry is expected to become a high-tech, modern industry with competitiveness and to participate in the global value chain.

To achieve those goals, the programme also outlines key solutions including institutional improvements, incentives to support and attract investment to the industry, particularly in R&D activities, technology transfer, and human resources development.

A report by the Drug Administration of Vietnam under the Ministry of Health shows that the total value of the Vietnamese pharmaceutical market grew from 2.7 billion USD in 2015 to 7 billion USD in 2022 and is forecast to reach more than 10 billion USD by 2026./. VNA